Jamieson, Stephen M F’s team published research in Journal of Medicinal Chemistry in 2012-09-13 | 115955-90-3

Journal of Medicinal Chemistry published new progress about Enzyme inhibitors. 115955-90-3 belongs to class tetrahydroisoquinoline, and the molecular formula is C9H12N2, Application of C9H12N2.

Jamieson, Stephen M. F.; Brooke, Darby G.; Heinrich, Daniel; Atwell, Graham J.; Silva, Shevan; Hamilton, Emma J.; Turnbull, Andrew P.; Rigoreau, Laurent J. M.; Trivier, Elisabeth; Soudy, Christelle; Samlal, Sharon S.; Owen, Paul J.; Schroeder, Ewald; Raynham, Tony; Flanagan, Jack U.; Denny, William A. published the artcile< 3-(3,4-Dihydroisoquinolin-2(1H)-ylsulfonyl)benzoic Acids: Highly Potent and Selective Inhibitors of the Type 5 17-β-Hydroxysteroid Dehydrogenase AKR1C3>, Application of C9H12N2, the main research area is isoquinolinylsulfonylbenzoic acid preparation AKR1C3 enzyme inhibitor structure activity; sulfonylbenzoic acid isoquinolinyl preparation AKR1C3 enzyme inhibitor structure activity.

A high-throughput screen identified 3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)benzoic acid as a novel, highly potent (low nM), and isoform-selective (1500-fold) inhibitor of aldo-keto reductase AKR1C3: a target of interest in both breast and prostate cancer. Crystal structure studies showed that the carboxylate group occupies the oxyanion hole in the enzyme, while the sulfonamide provides the correct twist to allow the dihydroisoquinoline to bind in an adjacent hydrophobic pocket. SAR studies around this lead showed that the positioning of the carboxylate was critical, although it could be substituted by acid isosteres and amides. Small substituents on the dihydroisoquinoline gave improvements in potency. A set of “”reverse sulfonamides””, e.g., I (R = CO2H, R1 = H; R = H, R1 = CO2H), showed a 12-fold preference for the R stereoisomer. The compounds showed good cellular potency, as measured by inhibition of AKR1C3 metabolism of a known dinitrobenzamide substrate, with a broad rank order between enzymic and cellular activity; but amide analogs were more effective than predicted by the cellular assay.

Journal of Medicinal Chemistry published new progress about Enzyme inhibitors. 115955-90-3 belongs to class tetrahydroisoquinoline, and the molecular formula is C9H12N2, Application of C9H12N2.

Referemce:
Tetrahydroisoquinoline – Wikipedia,
1,2,3,4-Tetrahydroisoquinoline | C9H11N – PubChem